Background
Type 1 diabetes affects the production of insulin in the body, requiring continual monitoring of blood glucose levels in order to prevent the worsening of symptoms, which in many cases lead to death. With the development of solutions to produce supplemental insulin emerging, the production of insulin is no longer problematic in developed countries. However, glucose monitoring is and continues to be a source of financial trouble for many people with Type 1 diabetes. The current method for measuring blood sugar levels in diabetics utilizes a blood sugar monitor and expensive testing strips. The most basic can cost at least of 30$ and test strips 1.38$ each(One Touch Ultra)1, and when taken into account that diabetics must test their blood at least five times a day with these non reusable strips, the glucose monitoring equipment can cost at a minimum 2500$ a year. In addition, insulin costs may be much higher, creating an even bigger burden.
|